97 related articles for article (PubMed ID: 24285685)
1. Genetic polymorphisms in 11β-hydroxysteroid dehydrogenase type 1 correlate with the postdexamethasone cortisol levels and bone mineral density in patients evaluated for osteoporosis.
Siggelkow H; Etmanski M; Bozkurt S; Groβ P; Koepp R; Brockmöller J; Tzvetkov MV
J Clin Endocrinol Metab; 2014 Feb; 99(2):E293-302. PubMed ID: 24285685
[TBL] [Abstract][Full Text] [Related]
2. HSD11B1 polymorphisms predicted bone mineral density and fracture risk in postmenopausal women without a clinically apparent hypercortisolemia.
Hwang JY; Lee SH; Kim GS; Koh JM; Go MJ; Kim YJ; Kim HC; Kim TH; Hong JM; Park EK; Lee JY; Kim SY
Bone; 2009 Dec; 45(6):1098-103. PubMed ID: 19651257
[TBL] [Abstract][Full Text] [Related]
3. A gene variant of 11β-hydroxysteroid dehydrogenase type 1 is associated with obesity in children.
Olza J; Gil-Campos M; Leis R; Rupérez AI; Tojo R; Cañete R; Gil A; Aguilera CM
Int J Obes (Lond); 2012 Dec; 36(12):1558-63. PubMed ID: 22310475
[TBL] [Abstract][Full Text] [Related]
4. The rs4844880 polymorphism in the promoter region of the HSD11B1 gene associates with bone mineral density in healthy and postmenopausal osteoporotic women.
Feldman K; Szappanos A; Butz H; Grolmusz V; Majnik J; Likó I; Kriszt B; Lakatos P; Tóth M; Rácz K; Patócs A
Steroids; 2012 Nov; 77(13):1345-51. PubMed ID: 22986073
[TBL] [Abstract][Full Text] [Related]
5. Circulating cortisone levels are associated with biochemical markers of bone formation and lumbar spine BMD: the Hertfordshire Cohort Study.
Cooper MS; Syddall HE; Fall CH; Wood PJ; Stewart PM; Cooper C; Dennison EM
Clin Endocrinol (Oxf); 2005 Jun; 62(6):692-7. PubMed ID: 15943831
[TBL] [Abstract][Full Text] [Related]
6. CYP2C9 genotype and association with bone mineral density: a pilot study.
Brunner-Ziegler S; Giurgea GA; Sunder-Plassmann R; Hammer A; Margeta C; Brunner M; Koppensteiner R; Mannhalter C
Gene; 2013 Sep; 526(2):295-8. PubMed ID: 23732294
[TBL] [Abstract][Full Text] [Related]
7. Primary male osteoporosis is associated with enhanced glucocorticoid availability.
Arampatzis S; Pasch A; Lippuner K; Mohaupt M
Rheumatology (Oxford); 2013 Nov; 52(11):1983-91. PubMed ID: 23882110
[TBL] [Abstract][Full Text] [Related]
8. Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density of the femoral neck in elderly Japanese women.
Yamada Y; Ando F; Niino N; Ohta S; Shimokata H
J Mol Med (Berl); 2002 Jul; 80(7):452-60. PubMed ID: 12110951
[TBL] [Abstract][Full Text] [Related]
9. Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments.
Quteineh L; Vandenberghe F; Saigi Morgui N; Delacrétaz A; Choong E; Gholam-Rezaee M; Magistretti P; Bondolfi G; Von Gunten A; Preisig M; Castelao E; Vollenweider P; Waeber G; Bochud M; Kutalik Z; Conus P; Eap CB
Pharmacogenet Genomics; 2015 May; 25(5):246-58. PubMed ID: 25751397
[TBL] [Abstract][Full Text] [Related]
10. BMD values and GSTM3 gene polymorphisms in combination with GSTT1/GSTM1 genes: a genetic association study in Slovenian elderly.
Jurkovic Mlakar S; Prezelj J; Osredkar J; Marc J
Gerontology; 2012; 58(3):238-48. PubMed ID: 22327174
[TBL] [Abstract][Full Text] [Related]
11. The 83,557insA variant of the gene coding 11β-hydroxysteroid dehydrogenase type 1 enzyme associates with serum osteocalcin in patients with endogenous Cushing's syndrome.
Szappanos A; Patócs A; Gergics P; Bertalan R; Kerti A; Acs B; Feldmann K; Rácz K; Tóth M
J Steroid Biochem Mol Biol; 2011 Jan; 123(1-2):79-84. PubMed ID: 21111044
[TBL] [Abstract][Full Text] [Related]
12. Association study of polymorphisms in the SOST gene region and parameters of bone strength and body composition in both young and elderly men: data from the Odense Androgen Study.
Piters E; de Freitas F; Nielsen TL; Andersen M; Brixen K; Van Hul W
Calcif Tissue Int; 2012 Jan; 90(1):30-9. PubMed ID: 22076526
[TBL] [Abstract][Full Text] [Related]
13. The effect of common genetic variation in 11β-hydroxysteroid dehydrogenase type 1 on hypothalamic-pituitary-adrenal axis activity and incident depression.
Dekker MJ; Tiemeier H; Luijendijk HJ; Kuningas M; Hofman A; de Jong FH; Stewart PM; Koper JW; Lamberts SW
J Clin Endocrinol Metab; 2012 Feb; 97(2):E233-7. PubMed ID: 22112815
[TBL] [Abstract][Full Text] [Related]
14. Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort.
Rubin LA; Hawker GA; Peltekova VD; Fielding LJ; Ridout R; Cole DE
J Bone Miner Res; 1999 Apr; 14(4):633-43. PubMed ID: 10234586
[TBL] [Abstract][Full Text] [Related]
15. Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the Framingham Osteoporosis Study.
Ferrari SL; Karasik D; Liu J; Karamohamed S; Herbert AG; Cupples LA; Kiel DP
J Bone Miner Res; 2004 Apr; 19(4):552-9. PubMed ID: 15005841
[TBL] [Abstract][Full Text] [Related]
16. Association of polymorphisms in the beta-2 adrenergic receptor gene with fracture risk and bone mineral density.
Veldhuis-Vlug AG; Oei L; Souverein PC; Tanck MW; Rivadeneira F; Zillikens MC; Kamphuisen PW; Maitland-van der Zee AH; de Groot MC; Hofman A; Uitterlinden AG; Fliers E; de Boer A; Bisschop PH
Osteoporos Int; 2015 Jul; 26(7):2019-27. PubMed ID: 25910744
[TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphisms in sFRP4 are associated with bone and body composition related parameters in Danish but not in Belgian men.
Boudin E; Piters E; Nielsen TL; Andersen M; Roef G; Taes Y; Brixen K; Van Hul W
Mol Genet Metab; 2012 Jul; 106(3):366-74. PubMed ID: 22608881
[TBL] [Abstract][Full Text] [Related]
18. Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts.
Figaro-Drumond FV; Pereira SC; Menezes IC; von Werne Baes C; Coeli-Lacchini FB; Oliveira-Paula GH; Cleare AJ; Young AH; Tanus-Santos JE; Juruena MF; Lacchini R
Behav Brain Res; 2020 Mar; 381():112343. PubMed ID: 31704233
[TBL] [Abstract][Full Text] [Related]
19. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.
Mencej S; Albagha OM; Prezelj J; Kocjan T; Marc J
J Mol Endocrinol; 2008 Jun; 40(6):273-9. PubMed ID: 18502820
[TBL] [Abstract][Full Text] [Related]
20. Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age.
Van Pottelbergh I; Goemaere S; Kaufman JM
J Clin Endocrinol Metab; 2003 Jul; 88(7):3075-81. PubMed ID: 12843146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
